Browse Studies — Arctuva

Phase 4

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

The purpose of this research study is to determine the effectiveness of adding deucravacitinib to the participant's current Psoriatic Arthritis (PsA) treatment…

Psoriatic Arthritis (PsA)

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT07280702

Phase 4

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects the joints but can also have an effect on multiple parts of the body. This study wil…

Psoriatic Arthritis (PsA)

Estimated

~$10 – $6,250

Medical College of WisconsinNCT07111494

Phase 4

A Randomized, Double-blind, Placebo-controlled Crossover Trial of Antiplatelet Therapies in Psoriasis

The purpose of this study is to determine the effect of antiplatelet therapy on the endovascular phenotype in psoriasis, specifically whether clopidogrel reduc…

Psoriasis (PsO)Psoriatic Arthritis (PsA)

Estimated

~$10 – $7,500

NYU Langone HealthNCT07744191

Unhide® Project Also Known as The Unhide® Solve Together Unified Platform

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle i…

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more

Estimated

~$10 – $1,125